Small caps round-up: Orchid, Iofina, Phytopharm
Cash is extremely tight at the Bulgaria focused property company Orchid Developments Group, especially after a recent planned sale asset failed to go ahead for reasons beyond the control of Orchid. The firm has warned that it 'cannot be certain that it can continue to operate with the full support of its creditors', meaning that its cash position is now more uncertain than previously stated. Consequently, the group is now considering the best way to address its immediate working capital needs.
Cash is extremely tight at the Bulgaria focused property company Orchid Developments Group, especially after a recent planned sale asset failed to go ahead for reasons beyond the control of Orchid. The firm has warned that it 'cannot be certain that it can continue to operate with the full support of its creditors', meaning that its cash position is now more uncertain than previously stated. Consequently, the group is now considering the best way to address its immediate working capital needs.
Iodine maker Iofina has successfully commissioned its IO#1 plant, marking a significant milestone for the firm. The tie-in to the electricity grid was completed on schedule in early August. The firm has now commenced processing iodine-rich brine from the producer's salt water disposal site and the company is now on track to become a major iodine producer.
Phytopharm, a developer of pharmaceuticals, is expecting the headline results from its phase two clinical study on its Cogane product in patients with Parkinson's disease in February 2013, saying it has already demonstrated efficacy in the "gold standard" pre-clinical model of ALS, the most common form of motor neurone disease. The firm is growing confident that the drug offers a potential treatment for the condition. The company is now preparing for a phase one study to evaluate Cogane solid dose formulations for up to 28 days.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
![https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748-320-80.jpg)
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
NR
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Regulator moves to protect access to cash amid branch closures and disappearing ATMs
News The Financial Conduct Authority has told banks to start assessing if local communities have adequate cash access from mid-September
By Marc Shoffman Published
-
VAT hike on private school fees could come earlier than previously expected
The government could start charging VAT on private school fees as soon as January 2025, according to the latest reports. What does it mean for parents?
By Katie Williams Published